Novartis sells parts of Sandoz U.S. to India’s Aurobindo for $900 million

Novartis AG said on Thursday it would sell the dermatology and generic U.S. oral solids portfolios of Sandoz U.S. to India’s Aurobindo Pharma Ltd for $900 million, as the Swiss drugmaker looks to focus on higher growth areas.

…read more

Source:: Reuters – Business News